Back to Organizations
Isomorphic Labs
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
London, United Kingdom
Current stage: Series BFunded in the last 6 months
Current Funding Stage
Series BCurrent recognized equity stage. The rounds below remain the historical funding record.
Funding Rounds
Funding Round: Series B
Funding Date: 12 May, 2026
Raised Amount: $2.1B
Funding Round: First external funding round
Funding Date: 31 Mar, 2025
Raised Amount: $600M